期刊文献+

高效液相色谱法测定制剂中本芴醇含量 被引量:1

Determination of benflumetol in its preparations by HPLC with UV detection
下载PDF
导出
摘要 目的建立本芴醇的含量测定方法。方法采用反相高效液相-紫外检测法,流动相为甲醇∶水∶冰醋酸∶二乙胺(体积比94.5∶4∶1∶0.5),流速0.8ml/min,检测波长335nm。结果本芴醇在2.0-200μg/ml范围内线性关系良好,以峰面积对本芴醇浓度进行线性回归,方程为A=43088C+49741,r=0.9998;日内、日间精密度RSD均小于2%;平均回收率在98%-102%之间。结论该高效液相色谱法实验操作简单方便,准确度、精密度及重现性等均符合药典要求,可为各种制剂中本芴醇的质量控制提供依据。 Objective To establish a method for determining the content of benflumetol in its preparations by HPLC with UV detection. Methods HPLC method was used with methanol-water-glacial acetic acid-diethylamine(94.5∶4∶1∶0.5,V/V/V/V)as the mobile phase at a flow rate of 0.8 ml/min.UV detection wave length was set at 335 nm. Results Benflumetol showed a good linearity in the range of 2.0-200 μg/ml.The lower limit of quantification was 2.0 μg/ml.The intra-day and inter-day RSDs were less than 2%.Mean recovery was 98.0%-102.0%. Conclusion The method is simple,accurate and precise,and could meet the requirement of quality control of benflumetol in its preparation.
出处 《山西医科大学学报》 CAS 2009年第3期250-253,共4页 Journal of Shanxi Medical University
基金 国家自然科学基金资助项目(30572367)
关键词 本芴醇 高效液相色谱法 含量测定 benflumetol HPLC assay
  • 相关文献

参考文献6

  • 1刘天伟,李志芳,孙晓文,屈凌波.复方蒿甲醚国际合作的回顾与思考[J].世界科学技术-中医药现代化,2004,6(4):44-53. 被引量:4
  • 2国家药典委员会编..中华人民共和国药典 2005年版 二部[M].北京:化学工业出版社,2005:924.
  • 3黄茂慧,樊哲群,秦莉花.反相高效液相色谱法测定本芴醇的有关物质[J].中南药学,2006,4(6):438-440. 被引量:2
  • 4Zeng Mei-Yi, Lu Zhi-Liang, Yang Song-Cheng, et al. Determination of benflumetol in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection [ J]. J Chromatogr B, 1996,681:299 - 306. 被引量:1
  • 5Lindegardh N, Annerberg A, Blessborn D, et al. Development and validation of a bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma[ J]. J Pharm Biomed Anal,2005,37:1081 - 1088. 被引量:1
  • 6Blessborn D, Romsing S, Annerberg A, et al. Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper [ J ]. J Pharm Biomed Anal, 2007,45 : 282 - 287. 被引量:1

二级参考文献22

  • 1WHO Expert Committee on the Selection and Use of Essential Medicines,"The selection and use of essential medicines (including the 12th Model List of Essential Medicines)", April 2002. 被引量:1
  • 2S Nwaka and RG Ridley. Virtual drug discovery and development for neglected diseases through public- private partnerships. Nature Reviews Drug Discovery,2003, Vol. 2, 919 ~ 928. 被引量:1
  • 3Peter B. Bloland,Drug resistance in malaria, WHO/CDS/CSR/DRS/2001.4. 被引量:1
  • 4WHO Malaria Control Department, IMPROVING THE AFFORDABILITY AND FINANCING OF ARTEMISININ - BASED COMBINATION THERAPIES, WHO/CDS/MAL/2003. 1095. 被引量:1
  • 5张礼和.文汇报[EB/OL].http://ww.cas.accn/html/dir/2003/02/28/7830. htm.,2003年2月28日. 被引量:1
  • 6WHO Technical Report No. 711, 1983. 被引量:1
  • 7Novartis, http: //www. malariaandhealth. com. 被引量:1
  • 8C. Souppart, N. Gauducheau, and N. Sandrenan, et al., Development and validation of a high- performance liquid chromatography- mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma. Journal of Chromatography B,2002, 774:195 - 203. 被引量:1
  • 9P. Skelton -Stxoud, R. Mull, and The Novartis Co -Artemther International Development Team, Mededias Tropieals(Marseille), 1998,58:77 - 81. 被引量:1
  • 10C Falade, M Makanga, Z Premji, et al., Efficacy and safety of artemether - lumefantrine (Coartem(r)) tablets (six - dose regimen) in African infants and children with acute, uncomplicated falciparum malaria, submitted to the NEJM on November 28, 2003. 被引量:1

共引文献4

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部